ID   RIR1_ECOLI              Reviewed;         761 AA.
AC   P00452; P78088; P78177;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   15-FEB-2017, entry version 176.
DE   RecName: Full=Ribonucleoside-diphosphate reductase 1 subunit alpha;
DE            EC=1.17.4.1;
DE   AltName: Full=Protein B1;
DE   AltName: Full=Ribonucleoside-diphosphate reductase 1 R1 subunit;
DE   AltName: Full=Ribonucleotide reductase 1;
GN   Name=nrdA; Synonyms=dnaF; OrderedLocusNames=b2234, JW2228;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6087316; DOI=10.1073/pnas.81.14.4294;
RA   Carlson J., Fuchs J.A., Messing J.;
RT   "Primary structure of the Escherichia coli ribonucleoside diphosphate
RT   reductase operon.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4294-4297(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=3287341; DOI=10.1093/nar/16.9.4174;
RA   Nilsson O., Aaberg A., Lundqvist T., Sjoeberg B.-M.;
RT   "Nucleotide sequence of the gene coding for the large subunit of
RT   ribonucleotide reductase of Escherichia coli. Correction.";
RL   Nucleic Acids Res. 16:4174-4174(1988).
RN   [3]
RP   SEQUENCE REVISION TO 526-527.
RA   Sjoeberg B.-M.;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3894026; DOI=10.1111/j.1432-1033.1985.tb09037.x;
RA   Sjoeberg B.-M., Eriksson S., Joernvall H., Carlquist M., Eklund H.;
RT   "Protein B1 of ribonucleotide reductase. Direct analytical data and
RT   comparisons with data indirectly deduced from the nucleotide sequence
RT   of the Escherichia coli nrdA gene.";
RL   Eur. J. Biochem. 150:423-427(1985).
RN   [8]
RP   ACTIVE SITES.
RX   PubMed=2663852;
RA   Aaberg A., Hahne S., Karlsson M., Larsson A., Ormoe M., Aahgren A.,
RA   Sjoeberg B.-M.;
RT   "Evidence for two different classes of redox-active cysteines in
RT   ribonucleotide reductase of Escherichia coli.";
RL   J. Biol. Chem. 264:12249-12252(1989).
RN   [9]
RP   ACTIVE SITES, AND MUTAGENESIS OF TYR-730 AND TYR-731.
RX   PubMed=8702814; DOI=10.1074/jbc.271.34.20655;
RA   Ekberg M., Sahlin M., Eriksson M., Sjoberg B.M.;
RT   "Two conserved tyrosine residues in protein R1 participate in an
RT   intermolecular electron transfer in ribonucleotide reductase.";
RL   J. Biol. Chem. 271:20655-20659(1996).
RN   [10]
RP   ENZYME REGULATION, AND INDUCTION BY HYDROXYUREA.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=20005847; DOI=10.1016/j.molcel.2009.11.024;
RA   Davies B.W., Kohanski M.A., Simmons L.A., Winkler J.A., Collins J.J.,
RA   Walker G.C.;
RT   "Hydroxyurea induces hydroxyl radical-mediated cell death in
RT   Escherichia coli.";
RL   Mol. Cell 36:845-860(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-283, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.M800187-MCP200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=8052308; DOI=10.1038/370533a0;
RA   Uhlin U., Eklund H.;
RT   "Structure of ribonucleotide reductase protein R1.";
RL   Nature 370:533-539(1994).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF MUTANTS ALA-441; ASP-441 AND
RP   GLN-441, DISULFIDE BOND, SUBUNIT, ACTIVE SITE, ENZYME REGULATION,
RP   ENZYME MECHANISM, AND MUTAGENESIS OF GLU-441.
RX   PubMed=9395490; DOI=10.1074/jbc.272.50.31533;
RA   Persson A.L., Eriksson M., Katterle B., Potsch S., Sahlin M.,
RA   Sjoberg B.M.;
RT   "A new mechanism-based radical intermediate in a mutant R1 protein
RT   affecting the catalytically essential Glu441 in Escherichia coli
RT   ribonucleotide reductase.";
RL   J. Biol. Chem. 272:31533-31541(1997).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEXES WITH ATP; GDP AND
RP   TTP, DISULFIDE BOND, SUBUNIT, AND ENZYME REGULATION.
RX   PubMed=9309223; DOI=10.1016/S0969-2126(97)00259-1;
RA   Eriksson M., Uhlin U., Ramaswamy S., Ekberg M., Regnstroem K.,
RA   Sjoeberg B.-M., Eklund H.;
RT   "Binding of allosteric effectors to ribonucleotide reductase protein
RT   R1: reduction of active-site cysteines promotes substrate binding.";
RL   Structure 5:1077-1092(1997).
RN   [15]
RP   STRUCTURE BY NMR OF 737-761, AND BINDING SITES.
RX   PubMed=10493864; DOI=10.1006/jmbi.1999.3067;
RA   Berardi M.J., Bushweller J.H.;
RT   "Binding specificity and mechanistic insight into glutaredoxin-
RT   catalyzed protein disulfide reduction.";
RL   J. Mol. Biol. 292:151-161(1999).
CC   -!- FUNCTION: Provides the precursors necessary for DNA synthesis.
CC       Catalyzes the biosynthesis of deoxyribonucleotides from the
CC       corresponding ribonucleotides. R1 contains the binding sites for
CC       both substrates and allosteric effectors and carries out the
CC       actual reduction of the ribonucleotide. It also provides redox-
CC       active cysteines.
CC   -!- CATALYTIC ACTIVITY: 2'-deoxyribonucleoside diphosphate +
CC       thioredoxin disulfide + H(2)O = ribonucleoside diphosphate +
CC       thioredoxin.
CC   -!- ENZYME REGULATION: Under complex allosteric control mediated by
CC       deoxynucleoside triphosphates and ATP binding to separate
CC       specificity and activation sites on the alpha subunit. The type of
CC       nucleotide bound at the specificity site determines substrate
CC       preference. It seems probable that ATP makes the enzyme reduce CDP
CC       and UDP, dGTP favors ADP reduction and dTTP favors GDP reduction.
CC       Stimulated by ATP and inhibited by dATP binding to the activity
CC       site. In vitro, its activity is increased by dithiothreitol (DTT)
CC       or thioredoxins (non-specific). Inhibited by hydroxyurea, leads to
CC       dNTP depletion, replication fork arrest and genomic instability
CC       (PubMed:20005847). {ECO:0000269|PubMed:9309223,
CC       ECO:0000269|PubMed:9395490, ECO:0000305|PubMed:20005847}.
CC   -!- PATHWAY: Genetic information processing; DNA replication.
CC   -!- SUBUNIT: Tetramer of two alpha (R1) and two beta (R2) subunits.
CC       The B1 protein is a dimer of alpha subunits. A radical transfer
CC       pathway occurs between 'Tyr-122' of R2 and R1.
CC       {ECO:0000269|PubMed:9309223, ECO:0000269|PubMed:9395490}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Alpha;
CC         IsoId=P00452-1; Sequence=Displayed;
CC       Name=Alpha';
CC         IsoId=P00452-2; Sequence=VSP_018871, VSP_018872;
CC   -!- INDUCTION: Induced 5-fold by hydroxyurea (at protein level).
CC       {ECO:0000269|PubMed:20005847}.
CC   -!- PTM: Binding of the substrate occurs primarily when the active-
CC       site cysteines are reduced.
CC   -!- MISCELLANEOUS: E.coli produces two separate class I enzymes. This
CC       one is the functional enzyme during growth.
CC   -!- MISCELLANEOUS: Two distinct regulatory sites have been defined:
CC       one controls substrate specificity and the other regulates the
CC       overall catalytic activity. A substrate-binding catalytic site,
CC       located on R1, is formed only in the presence of the second
CC       subunit R2.
CC   -!- SIMILARITY: Belongs to the ribonucleoside diphosphate reductase
CC       large chain family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA24223.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02672; AAA24223.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X06999; CAA30056.2; -; Genomic_DNA.
DR   EMBL; U00096; AAC75294.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16053.1; -; Genomic_DNA.
DR   PIR; H64993; RDEC1R.
DR   RefSeq; NP_416737.1; NC_000913.3.
DR   RefSeq; WP_001075164.1; NZ_LN832404.1.
DR   PDB; 1QFN; NMR; -; B=737-761.
DR   PDB; 1R1R; X-ray; 2.90 A; A/B/C=1-761.
DR   PDB; 1RLR; X-ray; 2.50 A; A=1-761.
DR   PDB; 2R1R; X-ray; 3.00 A; A/B/C=1-761.
DR   PDB; 2X0X; X-ray; 2.30 A; A/B/C=1-761.
DR   PDB; 2XAK; X-ray; 2.80 A; A/B/C=1-761.
DR   PDB; 2XAP; X-ray; 2.10 A; A/B/C=1-761.
DR   PDB; 2XAV; X-ray; 2.80 A; A/B/C=1-761.
DR   PDB; 2XAW; X-ray; 3.10 A; A/B/C=1-761.
DR   PDB; 2XAX; X-ray; 2.75 A; A/B/C=1-761.
DR   PDB; 2XAY; X-ray; 2.65 A; A/B/C=1-761.
DR   PDB; 2XAZ; X-ray; 2.60 A; A/B/C=1-761.
DR   PDB; 2XO4; X-ray; 2.50 A; A/B/C=1-761.
DR   PDB; 2XO5; X-ray; 2.70 A; A/B/C=1-761.
DR   PDB; 3R1R; X-ray; 3.00 A; A/B/C=1-761.
DR   PDB; 3UUS; X-ray; 5.65 A; A/B/C/D=1-761.
DR   PDB; 4ERM; X-ray; 3.95 A; A/B/C/D=1-761.
DR   PDB; 4ERP; X-ray; 4.45 A; A/B/C/D=1-761.
DR   PDB; 4R1R; X-ray; 3.20 A; A/B/C=1-761.
DR   PDB; 5CNS; X-ray; 2.98 A; A/B/C/D=1-761.
DR   PDB; 5CNT; X-ray; 3.25 A; A/B/C/D=1-761.
DR   PDB; 5CNU; X-ray; 3.40 A; A/B/C/D=1-761.
DR   PDB; 5CNV; X-ray; 3.20 A; A/B/C/D=1-761.
DR   PDB; 5R1R; X-ray; 3.10 A; A/B/C=1-761.
DR   PDB; 6R1R; X-ray; 3.10 A; A/B/C=1-761.
DR   PDB; 7R1R; X-ray; 3.10 A; A/B/C=1-761.
DR   PDBsum; 1QFN; -.
DR   PDBsum; 1R1R; -.
DR   PDBsum; 1RLR; -.
DR   PDBsum; 2R1R; -.
DR   PDBsum; 2X0X; -.
DR   PDBsum; 2XAK; -.
DR   PDBsum; 2XAP; -.
DR   PDBsum; 2XAV; -.
DR   PDBsum; 2XAW; -.
DR   PDBsum; 2XAX; -.
DR   PDBsum; 2XAY; -.
DR   PDBsum; 2XAZ; -.
DR   PDBsum; 2XO4; -.
DR   PDBsum; 2XO5; -.
DR   PDBsum; 3R1R; -.
DR   PDBsum; 3UUS; -.
DR   PDBsum; 4ERM; -.
DR   PDBsum; 4ERP; -.
DR   PDBsum; 4R1R; -.
DR   PDBsum; 5CNS; -.
DR   PDBsum; 5CNT; -.
DR   PDBsum; 5CNU; -.
DR   PDBsum; 5CNV; -.
DR   PDBsum; 5R1R; -.
DR   PDBsum; 6R1R; -.
DR   PDBsum; 7R1R; -.
DR   ProteinModelPortal; P00452; -.
DR   SMR; P00452; -.
DR   BioGrid; 4262130; 181.
DR   DIP; DIP-584N; -.
DR   IntAct; P00452; 9.
DR   MINT; MINT-1233906; -.
DR   STRING; 511145.b2234; -.
DR   EPD; P00452; -.
DR   PaxDb; P00452; -.
DR   PRIDE; P00452; -.
DR   EnsemblBacteria; AAC75294; AAC75294; b2234.
DR   EnsemblBacteria; BAA16053; BAA16053; BAA16053.
DR   GeneID; 946612; -.
DR   KEGG; ecj:JW2228; -.
DR   KEGG; eco:b2234; -.
DR   PATRIC; 32119827; VBIEscCol129921_2323.
DR   EchoBASE; EB0654; -.
DR   EcoGene; EG10660; nrdA.
DR   eggNOG; ENOG4105BZH; Bacteria.
DR   eggNOG; COG0209; LUCA.
DR   HOGENOM; HOG000278076; -.
DR   InParanoid; P00452; -.
DR   KO; K00525; -.
DR   OMA; YELLWQM; -.
DR   PhylomeDB; P00452; -.
DR   BioCyc; EcoCyc:NRDA-MONOMER; -.
DR   BioCyc; MetaCyc:NRDA-MONOMER; -.
DR   BRENDA; 1.17.4.1; 2026.
DR   SABIO-RK; P00452; -.
DR   UniPathway; UPA00326; -.
DR   EvolutionaryTrace; P00452; -.
DR   PRO; PR:P00452; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005971; C:ribonucleoside-diphosphate reductase complex; IDA:EcoliWiki.
DR   GO; GO:0005524; F:ATP binding; IDA:EcoliWiki.
DR   GO; GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; IDA:EcoCyc.
DR   GO; GO:0009263; P:deoxyribonucleotide biosynthetic process; IDA:EcoliWiki.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniPathway.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; IDA:EcoliWiki.
DR   InterPro; IPR005144; ATP-cone_dom.
DR   InterPro; IPR013346; NrdE_NrdA.
DR   InterPro; IPR000788; RNR_lg_C.
DR   InterPro; IPR013509; RNR_lsu_N.
DR   InterPro; IPR008926; RNR_R1-su_N.
DR   Pfam; PF03477; ATP-cone; 1.
DR   Pfam; PF02867; Ribonuc_red_lgC; 1.
DR   Pfam; PF00317; Ribonuc_red_lgN; 1.
DR   PRINTS; PR01183; RIBORDTASEM1.
DR   SUPFAM; SSF48168; SSF48168; 1.
DR   TIGRFAMs; TIGR02506; NrdE_NrdA; 1.
DR   PROSITE; PS51161; ATP_CONE; 1.
DR   PROSITE; PS00089; RIBORED_LARGE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Alternative initiation;
KW   ATP-binding; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; DNA replication; Nucleotide-binding; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN         1    761       Ribonucleoside-diphosphate reductase 1
FT                                subunit alpha.
FT                                /FTId=PRO_0000030596.
FT   DOMAIN        5     95       ATP-cone. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00492}.
FT   REGION       15     21       Allosteric activator binding.
FT   REGION      224    225       Substrate binding. {ECO:0000250}.
FT   REGION      437    441       Substrate binding. {ECO:0000250}.
FT   REGION      621    625       Substrate binding.
FT   ACT_SITE    437    437       Proton acceptor.
FT   ACT_SITE    439    439       Cysteine radical intermediate.
FT   ACT_SITE    441    441       Proton acceptor.
FT   BINDING       9      9       Allosteric activator.
FT   BINDING      55     55       Allosteric activator.
FT   BINDING      91     91       Allosteric activator.
FT   BINDING     209    209       Substrate.
FT   BINDING     253    253       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   SITE        225    225       Important for hydrogen atom transfer.
FT   SITE        232    232       Allosteric effector binding.
FT   SITE        262    262       Allosteric effector binding.
FT   SITE        462    462       Important for hydrogen atom transfer.
FT   SITE        730    730       Important for electron transfer.
FT   SITE        731    731       Important for electron transfer.
FT   SITE        754    754       Interacts with thioredoxin/glutaredoxin.
FT   SITE        759    759       Interacts with thioredoxin/glutaredoxin.
FT   MOD_RES     283    283       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18723842}.
FT   DISULFID    225    462       Redox-active.
FT                                {ECO:0000269|PubMed:9309223,
FT                                ECO:0000269|PubMed:9395490}.
FT   VAR_SEQ       1     25       Missing (in isoform Alpha').
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018871.
FT   VAR_SEQ      26     26       L -> M (in isoform Alpha').
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018872.
FT   VARIANT       1      2       Missing (in 15% of the chains).
FT   VARIANT       1      1       Missing (in 30% of the chains).
FT   MUTAGEN     441    441       E->A,Q: Loss of activity.
FT                                {ECO:0000269|PubMed:9395490}.
FT   MUTAGEN     441    441       E->D: Decrease in activity.
FT                                {ECO:0000269|PubMed:9395490}.
FT   MUTAGEN     730    730       Y->F: Loss of activity.
FT                                {ECO:0000269|PubMed:8702814}.
FT   MUTAGEN     731    731       Y->F: Loss of activity.
FT                                {ECO:0000269|PubMed:8702814}.
FT   STRAND        6      8       {ECO:0000244|PDB:2XAP}.
FT   STRAND       10     12       {ECO:0000244|PDB:2XAP}.
FT   STRAND       14     16       {ECO:0000244|PDB:2XAP}.
FT   HELIX        19     30       {ECO:0000244|PDB:2XAP}.
FT   HELIX        38     46       {ECO:0000244|PDB:2XAP}.
FT   HELIX        55     68       {ECO:0000244|PDB:2XAP}.
FT   STRAND       72     74       {ECO:0000244|PDB:2XAP}.
FT   HELIX        77     94       {ECO:0000244|PDB:2XAP}.
FT   STRAND       95     98       {ECO:0000244|PDB:2XAP}.
FT   HELIX       102    111       {ECO:0000244|PDB:2XAP}.
FT   HELIX       118    122       {ECO:0000244|PDB:2XAP}.
FT   HELIX       125    134       {ECO:0000244|PDB:2XAP}.
FT   HELIX       137    142       {ECO:0000244|PDB:2XAP}.
FT   HELIX       145    154       {ECO:0000244|PDB:2XAP}.
FT   TURN        160    162       {ECO:0000244|PDB:2XAP}.
FT   HELIX       169    180       {ECO:0000244|PDB:2XAP}.
FT   TURN        181    183       {ECO:0000244|PDB:2XAP}.
FT   TURN        186    188       {ECO:0000244|PDB:2XAP}.
FT   HELIX       189    201       {ECO:0000244|PDB:2XAP}.
FT   STRAND      204    206       {ECO:0000244|PDB:2XAP}.
FT   HELIX       209    214       {ECO:0000244|PDB:2XAP}.
FT   STRAND      217    219       {ECO:0000244|PDB:5CNS}.
FT   STRAND      225    229       {ECO:0000244|PDB:2XAP}.
FT   HELIX       234    248       {ECO:0000244|PDB:2XAP}.
FT   TURN        249    251       {ECO:0000244|PDB:2XAP}.
FT   STRAND      253    257       {ECO:0000244|PDB:2XAP}.
FT   STRAND      268    271       {ECO:0000244|PDB:1RLR}.
FT   HELIX       274    276       {ECO:0000244|PDB:5R1R}.
FT   HELIX       278    289       {ECO:0000244|PDB:2XAP}.
FT   TURN        290    292       {ECO:0000244|PDB:2XAP}.
FT   STRAND      296    299       {ECO:0000244|PDB:2XAP}.
FT   STRAND      301    307       {ECO:0000244|PDB:2XAP}.
FT   HELIX       313    317       {ECO:0000244|PDB:2XAP}.
FT   TURN        318    320       {ECO:0000244|PDB:2XAP}.
FT   STRAND      322    324       {ECO:0000244|PDB:2XAP}.
FT   HELIX       326    328       {ECO:0000244|PDB:2XAP}.
FT   STRAND      333    339       {ECO:0000244|PDB:2XAP}.
FT   HELIX       341    349       {ECO:0000244|PDB:2XAP}.
FT   STRAND      352    356       {ECO:0000244|PDB:2XAP}.
FT   HELIX       358    360       {ECO:0000244|PDB:2XAP}.
FT   HELIX       364    370       {ECO:0000244|PDB:2XAP}.
FT   HELIX       372    384       {ECO:0000244|PDB:2XAP}.
FT   STRAND      386    388       {ECO:0000244|PDB:2XAX}.
FT   STRAND      391    394       {ECO:0000244|PDB:2XAP}.
FT   HELIX       395    409       {ECO:0000244|PDB:2XAP}.
FT   STRAND      412    416       {ECO:0000244|PDB:2XAP}.
FT   HELIX       419    422       {ECO:0000244|PDB:2XAP}.
FT   STRAND      423    426       {ECO:0000244|PDB:2XAP}.
FT   TURN        428    430       {ECO:0000244|PDB:2XAP}.
FT   STRAND      438    440       {ECO:0000244|PDB:5CNS}.
FT   STRAND      463    468       {ECO:0000244|PDB:2XAP}.
FT   TURN        469    471       {ECO:0000244|PDB:2XAP}.
FT   HELIX       475    477       {ECO:0000244|PDB:2XAP}.
FT   HELIX       478    495       {ECO:0000244|PDB:2XAP}.
FT   HELIX       501    510       {ECO:0000244|PDB:2XAP}.
FT   STRAND      513    518       {ECO:0000244|PDB:2XAP}.
FT   HELIX       520    526       {ECO:0000244|PDB:2XAP}.
FT   STRAND      531    534       {ECO:0000244|PDB:2X0X}.
FT   HELIX       537    562       {ECO:0000244|PDB:2XAP}.
FT   HELIX       568    570       {ECO:0000244|PDB:2XAP}.
FT   HELIX       573    575       {ECO:0000244|PDB:2XAP}.
FT   HELIX       579    582       {ECO:0000244|PDB:2XAP}.
FT   HELIX       585    589       {ECO:0000244|PDB:2XAP}.
FT   HELIX       599    609       {ECO:0000244|PDB:2XAP}.
FT   STRAND      612    614       {ECO:0000244|PDB:2XO5}.
FT   HELIX       624    628       {ECO:0000244|PDB:2XAP}.
FT   STRAND      639    645       {ECO:0000244|PDB:2XAP}.
FT   STRAND      648    650       {ECO:0000244|PDB:5CNS}.
FT   STRAND      652    655       {ECO:0000244|PDB:2XAP}.
FT   HELIX       659    662       {ECO:0000244|PDB:2XAP}.
FT   TURN        663    665       {ECO:0000244|PDB:2XAP}.
FT   HELIX       669    671       {ECO:0000244|PDB:2XAP}.
FT   STRAND      672    675       {ECO:0000244|PDB:2XAK}.
FT   HELIX       676    686       {ECO:0000244|PDB:2XAP}.
FT   STRAND      697    699       {ECO:0000244|PDB:2XAP}.
FT   HELIX       701    703       {ECO:0000244|PDB:2XAP}.
FT   HELIX       705    707       {ECO:0000244|PDB:2XAP}.
FT   HELIX       711    723       {ECO:0000244|PDB:2XAP}.
FT   STRAND      732    734       {ECO:0000244|PDB:2XAP}.
FT   HELIX       738    741       {ECO:0000244|PDB:1RLR}.
SQ   SEQUENCE   761 AA;  85775 MW;  7E034F154567C3FC CRC64;
     MNQNLLVTKR DGSTERINLD KIHRVLDWAA EGLHNVSISQ VELRSHIQFY DGIKTSDIHE
     TIIKAAADLI SRDAPDYQYL AARLAIFHLR KKAYGQFEPP ALYDHVVKMV EMGKYDNHLL
     EDYTEEEFKQ MDTFIDHDRD MTFSYAAVKQ LEGKYLVQNR VTGEIYESAQ FLYILVAACL
     FSNYPRETRL QYVKRFYDAV STFKISLPTP IMSGVRTPTR QFSSCVLIEC GDSLDSINAT
     SSAIVKYVSQ RAGIGINAGR IRALGSPIRG GEAFHTGCIP FYKHFQTAVK SCSQGGVRGG
     AATLFYPMWH LEVESLLVLK NNRGVEGNRV RHMDYGVQIN KLMYTRLLKG EDITLFSPSD
     VPGLYDAFFA DQEEFERLYT KYEKDDSIRK QRVKAVELFS LMMQERASTG RIYIQNVDHC
     NTHSPFDPAI APVRQSNLCL EIALPTKPLN DVNDENGEIA LCTLSAFNLG AINNLDELEE
     LAILAVRALD ALLDYQDYPI PAAKRGAMGR RTLGIGVINF AYYLAKHGKR YSDGSANNLT
     HKTFEAIQYY LLKASNELAK EQGACPWFNE TTYAKGILPI DTYKKDLDTI ANEPLHYDWE
     ALRESIKTHG LRNSTLSALM PSETSSQISN ATNGIEPPRG YVSIKASKDG ILRQVVPDYE
     HLHDAYELLW EMPGNDGYLQ LVGIMQKFID QSISANTNYD PSRFPSGKVP MQQLLKDLLT
     AYKFGVKTLY YQNTRDGAED AQDDLVPSIQ DDGCESGACK I
//
